Akero Therapeutics (1AKRO.MI) Q1 2025 Earnings

28FebConfirmed
Q1 2025
-1.12
-1.06
-1.01
-0.95

Details

Expected EPS
-1.11900459
Actual EPS
-0.953964
Surprise EPS
0.17
Surprise Percent
+14.75%

Description

Akero Therapeutics (1AKRO.MI) has reported earnings of -0.953964 per share for Q1 2025.

0 Comments

Share your thoughts